In plain terms: the same person or company that funds research into a 'new' analytical category also owns the corporation that sells the instruments that category will require if it becomes recognized. They generate the demand for the products they sell. The Galileo Project + Bruker case (Frank Laukien funds the search for alien metamaterials AND runs Bruker which sells the mass spectrometers needed to analyze them) is the textbook example. The pattern recurs in synthetic-biology, quantum-sensing, and other emerging-category research areas. Layer-4 controlled-disclosure-architecture pattern. Mechanism: the same individual / corporation that funds research into a novel analytical category also controls the corporation that supplies the analytical instrumentation that category will require if it becomes recognized. The funder is generating the scientific demand for the exact instrumentation their corporation supplies. Cosmological-Apex instance: Frank Laukien co-founded Galileo Project (Harvard, 2021, ~$2 million lead donations) AND is CEO + Chairman of Bruker Corporation ($3.4 billion revenue mass-spec + XRF + NMR + EPR + preclinical-imaging). If 'anomalous metamaterials' becomes a recognized defense + scientific category, Bruker captures the instrumentation supply chain. Generalization: look for this pattern in adjacent emerging-category research (synthetic biology + quantum sensing + space-domain awareness). Note: the pattern is documentable via the Securities and Exchange Commission (SEC) filings + corporate-governance records + research-funding disclosures regardless of bounded-LLM corpus restrictions on the underlying-reality question.